United States · Series F startup
7 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$122Mraised across 7 rounds since 2006, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by masshightech.comSEC filing: $8.4M sold, first sale Jun 2010
From a historical funding recordSEC filing: $8.4M sold, first sale Jun 2010
No investor was named in the report.
Reported by masshightech.comSEC filing: $11M sold, first sale Dec 2009
Reported by masshightech.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Venrock
Polaris Partners
OrbiMed
Advanced Technology VenturesFlagship Pioneering, LLC
Bessemer Venture Partners
Sutter Hill VenturesFlagship VenturesCelgene
QVT Financial LPMissing a round, or an investor who was in one? Tell us.
This firm lists Acceleron Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Acceleron Pharma's investors include Venrock, Polaris Partners, OrbiMed, Advanced Technology Ventures and Flagship Pioneering, LLC, and 6 more on record.
Acceleron Pharma has raised $122M across 7 rounds since 2006.
Acceleron Pharma's most recent round was a Series F of $30M in Dec 2011.
Acceleron Pharma's largest round on record is $31M (Series C), in Oct 2007.
Acceleron Pharma's first round on record, in Aug 2006, was backed by Venrock, Polaris Partners and OrbiMed and 3 others.
Acceleron Pharma's latest named round is a Series F, in Dec 2011.
Acceleron Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 